Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials

Integrated Blood Pressure Control

Volumn 2, Issue , 2009, Pages 1-8

  Cuspidi, Cesare ^a,b   Negri, Francesca ^a,b   Giudici, Valentina ^b   Capra, Anna ^a   Sala, Carla ^c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Angiotensin II receptor blockers; Antihypertensive drugs; Carotid atherosclerosis; Ultrasonography

Indexed keywords

ALPHA TOCOPHEROL; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; FELODIPINE; FLUINDOSTATIN; FOSINOPRIL; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; ISRADIPINE; LACIDIPINE; LOSARTAN; METOPROLOL; NIFEDIPINE; PLACEBO; PRAVASTATIN; RAMIPRIL; UNINDEXED DRUG; VALSARTAN; VERAPAMIL;

ANTIHYPERTENSIVE ACTIVITY; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; LOW DRUG DOSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 77953462757     PISSN: None     EISSN: 11787104     Source Type: Journal    
DOI: 10.2147/ibpc.s5174     Document Type: Review

References (48)

1. Crouse JR, Toole JF, McKinney WM, et al. Risk factors for extracranial carotid artery atherosclerosis. Stroke. 1987;18:990-996.
2. Folson A, Eckfeldt J, Weitzman S, et al. for the ARIC Investigators. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size and physical activity. Stroke. 1994; 25:66-73.
3. Zanchetti A, Hennig H , Baurecht H, et al. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with intima-media thickness. J Hypertens. 2007;25:2463-2470.
4. Cuspidi C, Mancia G, Ambrosioni E, Pessina A, Trimarco B, Zanchetti A. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS). J Hum Hypertens. 2004;18:891-896.
5. Bots ML, Van Swieten JC, Breteler MM, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet. 1993;341: 1231-1237.
6. Davis PH, Dawson JD, Mahoney LT, Lauer RM. Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study. Circulation. 1999;100:838-842.
7. Cuspidi C, Valerio C, Negri F, et al. Prevalence and correlates of multiple organ damage in referred treated hypertensives: data from the ETODH Study. J Hum Hypertens. 2008;22:801-803.
8. Burke GL, Evans GW, Riley WA, et al; for the ARIC Study Group. Arterial wall thickness is associated with prevalent cardiovascular diseases in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) study. Stroke. 1995;26:386-391.
9. Zanchetti A, Crepaldi G, Bond MG, et al. Systolic and pulse blood pressure (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS Study Group. J Hypertens. 2001;19:79-88.
10. Toubol PJ, Labreuche J, Vicaut E, Amarenco P; on behalf of the GENIC Investigators. Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke. 1999;30:841-850.
11. Simon A, Gariepy J, Megnien JL, Levenson J. Intima-media thickness : a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159-169.
12. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128:262-269.
13. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007:25:1105-1187.
14. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992.
15. Ubels FL, Terpstra WF, Smit AJ. Carotid intima-media: influence of drug treatment and clinical implications. Neth J Med. 1999;55:188-195.
16. Mercuri M, Devi K. Quantitative ultrasonographic evaluation of the carotid arteries in hypertension. J Cardiovasc Risk. 1995;2:27-33.
17. Pignoli P, Tremoli E, Poli A, Paoletti R. Intimal plus medial thickness of arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1408.
18. Poli A, Tremoli E, Colombo A, Pignoli P, Paoletti R. Ultrasographic measurement of common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis. 1988;7:253-261.
19. Luisiani L, Visonà A, Pagnan A. Non-invasive study of arterial hypertension and carotid atherosclerosis. Stroke. 1990;21:410-414.
20. Bonithon-Kopp C, Scarabin PY, Taquet A, Toubol PJ, Malmejac A, Guize L. Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb. 1991;11:966-972.
21. Ferrieres J, Elias A, Ruidavets JB, et al. Carotid intima-media thickness and coronary artery disease in a low-risk population. J Hypertens. 1999;17:743-748.
22. Zanchetti A, Bond MG, Hennig M, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1998;16:949-961.
23. Chambless LE, Heiss G, Folson AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997;146:483-494.
24. Hollander M, Bots ML, Del Sol AI, et al. Carotid plaque increases the risk of stroke and subgroups of cerebral infarction in asymptomatic elderly: the Rotterdam Study. Circulation. 2002;105:2872-2877.
25. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Eng J Med. 1999;340:14-22.
26. Zanchetti A, Bond GM, Hennig M, et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis. Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation. 2002;106:2422-2427.
27. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range. Prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 206;37:87-92.
28. McMahon S, Sharpe N, Gamble G, et al. for the PART-2 Collaborative Research Group. Randomized, placebo-controlled trial of the angiotensin- converting enzyme inhibitor, ramipril in patients with coronary or other occlusive arterial disease. J Am Coll Cardiol. 2000;36:438-443.
29. Pitt B, Byington RP, Furberg CD, et al. for the PREVENT Investigators. Effects of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation. 2000;102:1503-1510.
30. Lonn EM, Yusuf S, Dzavik V, et al; for the SECURE Investigators. Effects of ramipril and vitamin E on atherosclerosis. The Study to Evaluate Carotid Ultrasound changes in patients treated with Ramipril and vitamin E (SECURE). Circulation. 2001;103:919-925.
31. Asselbergs FW, van Roon AR, Hillege HL, et al. Effects of fosinopril and pravastatin on carotid intima-media in subjects with increased albuminuria. Stroke. 2005;36:649-653.
32. Hedblad B, Wiikstrund J, Janzon L, Wedel H, Berglund G. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness main results from the beta-blocker cholesterol-lowering asymptomatic plaque study (BCAPS). Circulation. 2001;103:1721-1726.
33. Wang JG, Staessen JA, Li Y, et al. Carotid intima-media thickness and antihypertensive treatment. A meta-analysis of randomized controlled trials. Stroke. 2006;37:1933-1940.
34. Borhani NO, Mercuri M, Borhani NO, et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). JAMA. 1996;276:785-791.
35. Zanchetti A, Agabiti-Rosei E, Dal Palù C, Leonetti G, Magnani B, Pessina A; for the Verapamil in Hypertension and Atherosclerosis Study (VHAS) Investigators. The Verapamil in hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J Hypertens. 1998;16:1667-1676.
36. Simon A, Gariepy J, Moyse D, Levenson J. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. Circulation. 2001;103:2949-2954.
37. Zanchetti A, Crepaldi G, Bond GM, et al. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis. Principal results of PHYLLIS- A randomized double blind trial. Stroke. 2004;35:2807-2812.
38. Ferrario CM. Use of angiotensin II receptor blockers in animal models of atherosclerosis. Am J Hypertens. 2002;15:9S-13S.
39. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861-869.
40. Ludwig M, Stapff M, Ribeiro A, et al. Combination of the effects of losartan and atenolol on common carotid intima-media thickness in patients with hypertension: results of a 2-year, double blind, randomized, controlled study. Clin Ther. 2002;24:1175-1193.
41. Mortsell D, Malmqvist K, Held C, Kahan T. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared to atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigations versus Atenolol (SILVHIA) study. J Intern Med. 2007; 26:472-479.
42. Ariff B, Zambanini A, Vamadeva S, et al. Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension. Stroke. 2006;37:2381-2384.
43. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients. J Hum Hypertens. 2006;20:787-794.
44. Stumpe K, Agabiti-Rosei E, Zielinski T, et al. Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study. Ther Adv Cardiovasc Dis. 2007;1:97-106.
45. Ono H, Minatoguchi S, Watanabe K, et al. Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension. Hypertens Res. 2008;31:271-279.
46. Soma MR, Donetti E, Seregni R, et al. Effect of lacidipine on fatty and proliferative lesions induced in hypercholesterolaemic rabbits. Br J Pharmacol. 1996;118:215-218.
47. Cristofori P, Lanzoni A, Quartaroli M, et al. The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse. J Hypertens. 2000;18:1429-1436.
48. Taddei S, Virdis A, Ghiadoni L, et al. Effect of calcium antagonist or beta-blockade treatment on nitric oxide-dependent vasodilatation and oxidate stress in essential hypertensve patients. J Hypertens. 2001;19: 1379-1386.